Investment Rating - The report maintains an "Overweight" rating for the industry, with a focus on new consumption sectors such as beauty care, IP derivatives, and gold jewelry [6][29]. Core Insights - The October CPI performance exceeded expectations, with a year-on-year increase of 0.2%, higher than the consensus forecast of -0.04%. The core CPI, excluding food and energy, rose by 1.2%, marking the highest increase since March 2024 [4][24]. - The implementation of the new duty-free policy in Hainan has led to a surge in tourism consumption, with duty-free shopping amounting to 506 million yuan from November 1 to 7, representing a year-on-year growth of 34.86% [5][27]. - Key events in the beauty care sector include Kimberly-Clark's acquisition of Kenvue, expected to complete in the second half of 2026, and Amorepacific's Q3 operating profit increasing by 41% [4][24]. Summary by Sections Market Performance - For the week of November 3 to November 7, the retail trade, social services, and beauty care sectors saw changes of +0.31%, +0.11%, and -3.10% respectively, ranking 17th, 19th, and 31st among 31 primary industries [15][17]. Key Industry Data and News - The beauty care sector is highlighted by Kimberly-Clark's acquisition of Kenvue and Amorepacific's significant profit increase. Additionally, new medical devices have received regulatory approval [4][24]. - In the travel sector, the number of domestic flights increased by 4.9% compared to 2019, with a total of approximately 101,000 flights executed in the week [5][24]. - The IP derivatives market is seeing growth, with significant sales expected from the film "Wang Wang Mountain" and new store openings in the toy sector [5][28]. Investment Recommendations - The report recommends focusing on companies such as Shangmei Co., Juzhibio, Marubi, Runben, Proya, Chaohongji, and Furuida within the beauty care and new consumption sectors [6][29].

Core Insights - The cosmetics sector experienced a slight decline of 0.09% on November 11, with Lafang Jiahua leading the drop [1] - The Shanghai Composite Index closed at 4002.76, down 0.39%, while the Shenzhen Component Index closed at 13289.0, down 1.03% [1] Market Performance - Notable gainers in the cosmetics sector included: - Yusong Co., Ltd. (300132) with a closing price of 8.08, up 3.59% and a trading volume of 703,100 shares, totaling 569 million yuan [1] - Bavi Co., Ltd. (920123) with a closing price of 18.18, up 2.42% and a trading volume of 35,200 shares, totaling 63.21 million yuan [1] - Lafang Jiahua (603630) closed at 23.17, down 1.45%, with a trading volume of 50,100 shares, totaling 116 million yuan [2] - The overall net capital flow in the cosmetics sector showed a net outflow of 64.16 million yuan from main funds, while retail funds saw a net inflow of 28.82 million yuan [2][3] Capital Flow Analysis - Main funds showed significant outflows in several companies: - Jiahen Jiahua (300955) had a main fund net outflow of 15.26 million yuan, with a retail net inflow of 21.48 million yuan [3] - Lafang Jiahua (603630) experienced a main fund net outflow of 7.23 million yuan, but retail funds saw a net inflow of 9.61 million yuan [3] - Shanghai Jahwa (600315) had a main fund net inflow of 1.61 million yuan, while retail funds had a net outflow of 12.56 million yuan [3]

Group 1 - The Beijing team was eliminated from the men's basketball quarter-finals of the 15th National Games, losing to the Sichuan team with a score of 76 to 89, thus stopping at the top eight [1][4] - Zhou Qi from the Sichuan team scored the highest points in the game with 33, playing a crucial role in determining the outcome [2][3] - The Beijing team faced significant injury issues, with key players unable to participate, resulting in only 10 players available for the match [1][2] Group 2 - The Sichuan team, which maintained a perfect record in the group stage, showcased strong performance with a roster that included players from last season's CBA champion Zhejiang Guangsha [1][2] - Despite the loss, the Beijing team will continue to compete in the ranking matches for positions 5 to 8 in the National Games [5] - The upcoming CBA season is set to begin in a month, with the Beijing Shougang team aiming for the championship after strengthening their roster [5]

Investment Rating - The report suggests a positive investment outlook for the beauty and personal care sector, recommending a "buy" rating for high-growth companies with strong brand power and innovative product offerings [2][3]. Core Insights - The beauty and personal care sector is experiencing a slow recovery, with significant differentiation among sub-sectors. Personal care products and innovative channels continue to perform strongly, while the cosmetics sector shows signs of slowing growth due to domestic brand competition [1][2][3]. - For 2026, the overall beauty and personal care market is expected to remain stable, but further differentiation among companies is anticipated. The report emphasizes the importance of selecting high-growth targets with product and channel innovations [2][3]. Summary by Sections Overall Market Performance - In the first three quarters of 2025, the beauty and personal care sector saw revenues and net profits increase by 2.7% and 4.9% respectively, with personal care outperforming cosmetics and medical aesthetics [12][31]. - The cosmetics sector experienced a slight decline in revenue, with a 0.4% decrease year-on-year, while net profit fell by 2.3% [31][33]. Personal Care Sector - The personal care segment achieved revenues of 52 billion yuan and net profits of 5 billion yuan, reflecting a year-on-year increase of 33.7% and 5.7% respectively. The third quarter alone saw a revenue increase of 41.1% [12][16]. - Companies like Ruoyuchen reported impressive growth, with a 123% increase in revenue and a 73% increase in net profit in the third quarter [12][28]. Cosmetics Sector - The cosmetics sector's revenue for the first three quarters was 308 billion yuan, with a net profit of 30 billion yuan, showing a decline of 0.4% and 2.3% respectively. The third quarter saw a revenue drop of 0.5% but a significant profit increase of 50.8% [12][31]. - The report highlights the importance of individual company strategies and product life cycles in determining performance within the cosmetics sector [13][48]. Medical Aesthetics Sector - The medical aesthetics segment reported revenues of 75 billion yuan and net profits of 27 billion yuan, with a slight revenue decline of 0.7% but a profit increase of 14.5% year-on-year [12][52]. - The third quarter saw a revenue increase of 1.8% and a remarkable profit growth of 96.6%, although underlying performance was affected by increased competition and integration challenges [52][56]. Investment Recommendations - The report recommends focusing on high-growth companies with strong brand power, such as Ruoyuchen, Shangmei, and Maogeping, as well as companies with stable fundamentals and potential for marginal improvement like Dengkang Oral and Shanghai Jahwa [2][3]. - It also suggests monitoring companies that are expected to reach a turning point, such as Runben and Jinjian Biological, which may present investment opportunities [2][3].

1. Report Industry Investment Rating - The industry rating is "Bullish" [1] 2. Core Views of the Report - The cosmetics industry continues to show differentiation, with brand demand being weak in the off - season, agents seeking change in difficult situations, and producers seizing supply - chain reconstruction opportunities. The medical aesthetics industry has new entrants with better - than - expected shipments, and new product catalysts are worth attention [3][4] 3. Summaries According to Relevant Catalogs 3.1 Cosmetics: Continued Differentiation 3.1.1 Brand Merchants - In 1 - 3Q25, beauty brand merchants' revenue was 28.4 billion yuan, a year - on - year decrease of 0.6%; personal care brand merchants' revenue was 5.7 billion yuan, a year - on - year increase of 12.4%. In 3Q25, beauty and personal care brand merchants' revenues were 8.05 billion and 1.805 billion yuan, a year - on - year decrease of 1.3% and an increase of 7.6% respectively. Beauty revenue weakened quarter - on - quarter, while personal care remained flat [18] - Beauty: Affected by the earlier Double Eleven promotion, consumer enthusiasm declined in September, and brands reduced live - streaming activities. In terms of single - quarter revenue growth, Shuiyang Co., Ltd. and Shanghai Jahwa increased by over 20%, Marubi Co., Ltd. had double - digit growth, Proya had low - double - digit decline, and Betaine and Freda had high - single - digit decline [18] - Personal care: Runben Co., Ltd.'s Q3 revenue increased by 17% year - on - year, with a slight increase in growth rate quarter - on - quarter. Baiya Co., Ltd.'s 3Q25 revenue improved, and Dengkang Oral Care had steady growth [18] - In 1 - 3Q25, beauty brand merchants' net profit after non - recurring items was 2.33 billion yuan, a year - on - year decrease of 15%; personal care brand merchants' was 604 million yuan, a year - on - year decrease of 3.4%. Some companies showed initial cost - control effects [24] 3.1.2 Agents - Agents are seeking change in difficult situations by exploring three paths: incubating self - owned brands (represented by Ruoyuchen), using AI to reduce costs and increase efficiency (represented by Yiwow), and expanding high - growth categories (such as Qingmu Technology expanding into trendy toy agency operations) [30] - Ruoyuchen's self - owned brands Feicui and Zhanjia continued to gain momentum. In Q3, self - owned brand revenue was 451 million yuan, a year - on - year increase of 344.5%, accounting for 55.1%. Zhanjia's Q3 revenue was 227 million yuan, a year - on - year increase of 119%, and 1 - 3Q revenue was 680 million yuan. Feicui's Q3 revenue was 203 million yuan, a quarter - on - quarter increase of over 98.8%, and 1 - 3Q revenue was 362 million yuan [30] 3.1.3 Producers - Demand continued to recover, and the revenue of the producer sector increased by 9%, 17%, and 30% year - on - year from Q1 to Q3, with the growth rate increasing quarter by quarter [33] - QingSong Co., Ltd. focused on optimizing customers and product structure, and its profit turned positive for four consecutive quarters from 2Q24 to 1Q25. Jieya Co., Ltd. had increasing orders from overseas big customers, and its Q3 performance growth accelerated. Jiaheng Home Co., Ltd. increased revenue but not profit, mainly due to the short - term impact of the Huzhou base's capacity ramp - up [33] 3.2 Medical Aesthetics: New Entrants with Better - than - Expected Shipments 3.2.1 Upstream Consumables - The growth rate of demand expansion slowed down, and supply - side competition intensified. In terms of the cumulative number of Class III medical device approvals, hyaluronic acid > regenerative (Sculptra/Poly - L - Lactic Acid) > botulinum toxin > recombinant collagen. Old products of hyaluronic acid and regenerative types faced growth pressure, and the growth rate of recombinant collagen Class III medical device products slowed down significantly quarter - on - quarter [38] - Hyaluronic acid: Aimeike's revenue growth rate from 24Q1 to 25Q3 was + 28.2%/+2.3%/+1.1%/ - 7%/ - 18%/ - 25%/ - 21% year - on - year, showing a quarterly decline since 24Q2 [38] - Collagen: Jinbo Biotech's revenue growth rate from 24Q1 to 25Q1 was + 76%/+100%/+92%/+73%/+63% year - on - year, and in 2Q25/3Q25, it was + 30%/+13% year - on - year. On October 23, the "Recombinant Type I α1 Subtype Collagen Freeze - Dried Fiber" Class III medical device certificate of Giant Biogene was approved by NMPA [38] - Leapmed Medical's medical aesthetics shipments were better than expected, with Q3 medical service and health management business revenue of 320 million yuan, a year - on - year increase of 28%, and the revenue of Sculptra and Hydrodermabrasion reaching 86.1367 million yuan [36] 3.2.2 Downstream - The new model of Xinoxygen Medical Clinics showed high - growth potential. The Q3 revenue guidance was 150 - 170 million yuan, a year - on - year increase of 231% - 275%, and a quarter - on - quarter increase of 4% - 18%. It plans to implement the "100 - City, 1000 - Store" plan in the long term [40] - Stores are expanding from first - tier cities to new first - tier and second - tier cities. As of November 6, it covered 42 stores in 10 cities. The promotion of self - owned brands was remarkable, and it cooperated with Xihong Miracle Sculptra 3.0, priced at 2999 yuan, which was officially launched on September 25 [43] 3.3 Investment Recommendations - Brands with upward potential and both growth and certainty: Recommend Maogeping (Oriental aesthetics, dual - wheel drive of makeup and skincare, and the second - curve of perfume is worth looking forward to) and Shangmei Co., Ltd. (with one cornerstone brand, five growth brands, and N seed businesses) [8][46] - Companies with new product pipelines and expected performance elasticity: Pay attention to Giant Biogene and Leapmed Medical [8][46] - Companies in strategic adjustment and expected to reach an inflection point: Recommend Shuiyang Co., Ltd. (the effect of high - end transformation is gradually emerging), and pay attention to Shanghai Jahwa, Betaine, and Freda [8][46]

Core Insights - The retail industry is experiencing a shift from value preservation to emotional value, with a focus on high-growth segments for investment opportunities [5][28] - The report maintains a positive outlook on the retail sector, emphasizing the importance of consumer insights and differentiated product offerings [5][28] Retail Market Overview - The retail index reported a slight increase of 0.31% during the week of November 3 to November 7, 2025, underperforming the Shanghai Composite Index, which rose by 1.08% [7][16] - Year-to-date, the retail index has increased by 4.20%, lagging behind the Shanghai Composite Index's 19.27% growth [16][20] Investment Strategy for 2026 - The investment strategy highlights four main themes: 1. **Gold and Jewelry**: Focus on high-end and fashionable gold segments, with recommendations for brands like Lao Pu Gold and Chao Hong Ji [5][48] 2. **Retail E-commerce**: Emphasize the transformation of offline retail to enhance service and experience, with key players like Yonghui Supermarket and Ai Ying Shi [5][48] 3. **Cosmetics**: Target domestic brands that capture emotional value and innovate on safety ingredients, recommending brands like Juzi Biological and Pechoin [5][49] 4. **Medical Aesthetics**: Focus on differentiated product manufacturers and expanding medical institutions, with recommendations for brands like Ai Mei Ke and Ke Di-B [5][49] Sector Performance - The jewelry sector is undergoing significant changes due to rising gold prices and a decline in traditional wedding markets, leading to the emergence of brands with strong consumer insights [5][29] - The cosmetics sector is seeing a rise in domestic brands leveraging cultural roots and emotional value to capture market share [5][41] Company-Specific Insights - **Chao Hong Ji**: Reported a revenue increase of 28.4% year-on-year for the first three quarters of 2025, with a notable performance in Q3 [54] - **Yonghui Supermarket**: Experienced a revenue decline of 22.2% year-on-year for the first three quarters of 2025, but is undergoing significant transformation [50] - **Juzi Biological**: Achieved a revenue growth of 21.7% year-on-year for the first half of 2025, focusing on collagen products [50]

Market Overview - The cosmetics sector experienced a decline of 0.24% on November 7, with Jiaheng Jiahua leading the drop [1] - The Shanghai Composite Index closed at 3997.56, down 0.25%, while the Shenzhen Component Index closed at 13404.06, down 0.36% [1] Individual Stock Performance - Qing Song Co. (300132) saw an increase of 2.61%, closing at 7.46 with a trading volume of 332,800 shares and a turnover of 246 million [1] - Jiaheng Jiahua (300955) led the decline with a drop of 4.99%, closing at 34.85 with a trading volume of 36,400 shares and a turnover of 129 million [2] - Other notable performers include: - Wanmei Biological (603983) up 0.78% to 33.56 [1] - Shuiyang Co. (300740) up 0.62% to 20.96 [1] - Furuida (600223) down 0.52% to 7.77 [1] Capital Flow Analysis - The cosmetics sector saw a net outflow of 43.89 million from institutional investors, while retail investors experienced a net inflow of 13.79 million [2] - Notable capital flows include: - Qing Song Co. (300132) had a net inflow of 37.12 million from institutional investors [3] - Jiaheng Jiahua (300955) experienced a net outflow of 11.10 million from institutional investors [3] - Furuida (600223) had a significant net outflow of 7.78 million from institutional investors [3]

Market Overview - The cosmetics sector experienced a decline of 1.21% on November 6, with Betaini leading the drop [1] - The Shanghai Composite Index closed at 4007.76, up 0.97%, while the Shenzhen Component Index closed at 13452.42, up 1.73% [1] Individual Stock Performance - Notable gainers included: - Shuiyang Co., Ltd. (300740) with a closing price of 20.83, up 1.46% [1] - Qingsong Co., Ltd. (300132) with a closing price of 7.27, up 1.11% [1] - Significant decliners included: - Betaini (300957) with a closing price of 42.22, down 4.89% [2] - Jiahen Home Care (300955) with a closing price of 36.68, down 3.47% [2] Trading Volume and Capital Flow - The cosmetics sector saw a net outflow of 82.6352 million yuan from institutional investors, while retail investors had a net inflow of 58.2199 million yuan [2] - The trading volume for Shuiyang Co., Ltd. was 149,100 shares, with a transaction value of 311 million yuan [1] Capital Flow Analysis - Major net inflows were observed in: - Shuiyang Co., Ltd. with a net inflow of 23.1839 million yuan [3] - Qingsong Co., Ltd. with a net inflow of 7.1227 million yuan [3] - Major net outflows were noted in: - Betaini with a net outflow of 90.237 million yuan [3] - Shanghai Jahwa (600315) with a net outflow of 90.237 million yuan [3]

Core Viewpoint - The emergence of the new skincare brand Key C (珂谧) by the company Furuida (福瑞达) marks a strategic shift from its traditional real estate and hyaluronic acid business to the collagen protein skincare market, aiming to differentiate itself through innovative technology and competitive pricing [1][2][4]. Company Transformation - Furuida, originally focused on real estate, has transitioned to the cosmetics sector, with its two existing brands, Yilian and Aier Doctor, contributing significantly to its revenue [4][5]. - In 2023, Furuida officially established a cosmetics-led business direction as its brands became the main revenue contributors [4][5]. Market Context - The beauty industry is experiencing a slowdown, and the competition in the collagen protein segment is intensifying, making Key C's entry particularly noteworthy [2][6]. - The overall revenue for Furuida's cosmetics segment in 2024 was 2.475 billion yuan, showing only a slight increase of 2.46% year-on-year, with Yilian's revenue at 963 million yuan (up 12.36%) and Aier Doctor's at 1.301 billion yuan (down 3.48%) [4][6]. Product Differentiation - Key C focuses on affordable medical beauty, utilizing transdermal penetration technology to compete against high-end anti-aging products priced in the thousands [2][6]. - The brand has achieved seven Class II medical device certifications and is developing additional Class III medical device projects, enhancing its credibility in the medical beauty space [7][8]. Pricing Strategy - Key C's pricing strategy is aimed at capturing market share through high cost-performance products, with its best-selling transdermal collagen essence priced at 600 yuan for 56 units, which can drop to 332 yuan during promotional events [8][10]. - This pricing approach disrupts the long-standing premium pricing of collagen products while maintaining a focus on effective ingredients [10][12]. Technological Innovation - Key C's transdermal penetration technology claims to improve skin absorption rates by 27.5 times compared to standard collagen products, addressing a significant industry challenge [11][12]. - The technology involves embedding transdermal peptide segments into the collagen sequence, allowing for effective penetration without compromising the integrity of the collagen [11][12]. Industry Challenges - The collagen protein market has faced scrutiny, with previous market leaders experiencing significant declines in market value, averaging over 40% from their peak [16][17]. - Consumer skepticism regarding the efficacy of collagen products has increased, leading to a more cautious approach from investors and the market [19][20]. Strategic Opportunities - Key C's entry into the collagen protein market represents a potential opportunity for differentiated competition amid industry challenges, contingent on its ability to innovate, educate consumers, and balance online and offline operations [19][20].

Group 1: Industry Overview - The cosmetics retail sales in China grew by 3.9% year-on-year from January to September 2025, slightly underperforming the overall retail market by 0.6 percentage points, indicating a stable demand environment [4][14]. - Online platforms like Tmall and Douyin are experiencing a shift, with Tmall showing signs of recovery due to flash sales and member subsidies, while Douyin's growth has slightly slowed down [17][20]. - The demand for high-end and cost-effective products is increasing, while the mid-range segment is facing pressure due to a more conservative consumer environment [5][41]. Group 2: Competitive Landscape - The trend of domestic brands replacing foreign ones is slowing down, with leading foreign brands like L'Oréal and Estée Lauder showing signs of recovery in the Chinese market [23][24]. - The growth of domestic brands is becoming more differentiated, with some brands like Proya and Shiseido experiencing declines, while others like Youngor and Shanghai Jahwa continue to grow [23][24]. - The industry is witnessing an acceleration in the multi-brand matrix among leading companies, which is expected to increase market concentration [27][28]. Group 3: Key Companies - The report highlights several companies with strong growth potential, including Ruya Chen, Shumei Co., and Maogeping, which are expected to benefit from their brand strength and market positioning [3][54]. - Companies like Dekang Oral Care and Shanghai Jahwa are noted for their stable fundamentals and potential for marginal improvement, while others like Jinbo Biological and Huaxi Biological are anticipated to reach turning points [54]. - Ruya Chen's self-owned brand, Zhenjia, has shown significant growth, with a revenue increase of 345% year-on-year in Q3 2025, indicating strong brand development capabilities [60].